This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
News|Articles|February 23, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-01-2017
- Volume 12
- Issue 3
PfizerCentreOne Expands Fill/Finish Services in Michigan
Author(s)Pharmaceutical Technology Editors
The company expanded fill/finish services at its facility in Kalamazoo, Michigan.
Advertisement
On Feb. 16, 2017, Pfizer CentreOne announced that it has expanded fill/finish services to its Kalamazoo, Michigan facility. Along with vial-filling of small molecules and biologics, the facility also provides vial-filling of sterile suspensions, expanding the company’s service portfolio. The Kalamazoo facility currently supplies drugs to more than 100 countries around the world.
Services at the Kalamazoo site now encompass small molecules and biologics, sterile suspensions, potent and controlled substances, aqueous and oil-based formulations, lyophilization, and vials 1–100mL; bulk formulation <1–1600 liters. The Kalamazoo facility also has dedicated, onsite technical, manufacturing science, regulatory affairs, and quality teams.
Source:
Articles in this issue
over 9 years ago
Viewpoint: No Clear Path for Pharma or Outsourcingover 9 years ago
Standards Set Excipient GMPs, But Collaboration is Neededover 9 years ago
Monitoring Supply Chain Risk on a Limited Budgetover 9 years ago
Evaluating E&L Studies for Single-Use Systemsover 9 years ago
Metrohm USA Announces Winner of Young Chemist Awardover 9 years ago
Novasep Opens New Bioconjugation Unit in Franceover 9 years ago
Recipharm Completes Kemwell AcquisitionAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
5